Skip Navigation

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (70)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Weston, A.
Right arrow Articles by Harris, C. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Weston, A.
Right arrow Articles by Harris, C. C.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 1994 Oxford University Press

research-article

Determination of the allelic frequencies of an L-myc and a p53 polymorphism in human lung cancer

Ainsley Weston 1, Helen M. Ling-Cawley, Neil E. Caporaso 2, Elise D. Bowman, Robert N. Hoover 3, Benjamin F. Trump 4 and Curtis C. Harris

Laboratory of Human Carcinogenesis, National Cancer Institute, National Institutes of Health Bethesda, MD 20892, USA
2Genetic Epidemiology Branch, National Cancer Institute, National Institutes of Health Bethesda, MD 20892, USA
3Environmental Epidemiology Branch, National Cancer Institute, National Institutes of Health Bethesda, MD 20892, USA
4Department of Pathology, University of Maryland, School of Medicine 10 South Pine Street, Baltimore, MD 21201, USA

1Present address, to where correspondence should be sent: Environmental Health Sciences Center, Mount Sinai Medical Center, 1 Gustave L.Levy Place, New York, NY 10029, USA

The L-myc and p53 genes have been implicated in lung cancer. Both of these genes have restriction fragment length polymorphisms (RFLPs) that could account for differential expression or activity of variant forms. An EcoRI restriction site in the L-myc gene was previously reported to be a predictor of poor prognosis in Japanese lung cancer patients. There are several RFLPs in the p53 gene. In exon 4 there is a polymorphism that codes for either an arginine or proline residue at codon 72. We previously reported the frequency of DNA-RFLPs at these gene loci revealed by EcoRI and AccII respectively. Here we report results from a study comparing lung cancer cases (n = 31) with chronic obstructive pulmonary disease controls (n = 49). No association was found between these RFLPs and disease status. Previous observations that the frequencies of these RFLPs varied by race were confirmed. The p53 arginine allele was found to be more common in Caucasians (0.71) than African Americans (0.50). The EcoRI restriction site present allele in L-myc was more frequent in African-Americans (0.71) than Caucasians (0.49). Thus, the allelic frequency for L-myc was similar in African Americans to that reported for Japanese, and the allelic frequency for p53 was similar in Caucasians to that reported for Japanese.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.